Independent Pharmacy: Power, Policy & Patient Care | TWIRx
- 1h 17m
- Transcript
Summary
Written by a model from the transcript; not yet reviewed.
This episode covers major policy, clinical, and technological updates impacting independent community pharmacy. The host and guests discuss the FDA's interim access policy for compounded peptides, significant clinical approvals like GSK's Hibsago for chronic hepatitis B, and Celaron RX's reported quarterly revenue. The conversation then focuses on Independent Pharmacy Cooperative expanding its government relations team with policy veterans like John Covelo, Dylan McGary, and Henry McQuaid to advocate for PBM reform and rural health access. Later segments explore the $50 billion Federal Rural Health Transformation Program and IPC's collaboration with Tenovi to integrate remote patient monitoring and remote therapeutic monitoring into community pharmacies to improve chronic disease management and patient outcomes.
- Pharmacists can utilize Federal Rural Health Transformation Program grants to fund remote dispensing and AI workflow tools. 24:22
- Independent pharmacies should invest in state and federal association memberships as professional insurance for advocacy. 30:44
- Remote patient monitoring devices using cellular gateways help simplify data collection for chronic condition management. 1:14:02
- Community pharmacists can leverage remote monitoring data to intervene early when patients experience medication side effects. 49:38
Chapters
- 0:03Podcast Introduction and Host Overview
The episode opens with the hosts welcoming listeners and introducing Todd Urie, the founder of the Pharmacy Podcast Network.
- 0:54FDA Interim Access Policy for Compounded Peptides
Discussion of the FDA’s proposed policy allowing temporary enforcement discretion for certain compounded peptides and its implications for pharmacists.
- 2:08Approval of GSK’s Hibsago for Hepatitis B
The FDA’s approval of Hibsago, a treatment for chronic hepatitis B, is highlighted along with its potential to achieve functional cure in a subset of patients.
- 3:13Rise of Specialty Pharmacy and PBM Consolidation
An overview of the growing financial power of specialty pharmacies, PBMs, insurers, and the impact on independent pharmacies.
- 4:49Rare Disease Treatment: Bitopertin Phase 3 Results
Positive phase 3 results for Bitopertin, an ingestible treatment for a rare disorder that reduces sun-induced pain.
- 5:53Workforce Challenges in Retail Pharmacies
Reddit discussions reveal prescription backlogs, staffing shortages, and the strain on pharmacists and technicians in large chain pharmacies.
- 10:17IPC Expansion of Government Relations Team
IPC announces a larger government relations team to advocate for independent pharmacies on PBM reform, reimbursement, and rural health access.
- 59:09Remote Monitoring Emphasis on Outcomes
Discussion of how RPM programs will increasingly tie reimbursement to measurable outcomes and the importance of ROI for providers.
- 1:01:53Rural Pilot Success and Patient Engagement
A small rural pilot showed patients felt more monitored and connected, highlighting the value of community pharmacy involvement in remote care.
- 1:03:26Population Aging and Community Pharmacy Opportunities
The aging baby boomer population will need local care as hospital beds dwindle, positioning community pharmacies as essential providers.
- 1:08:49Proactive Physician–Pharmacy Collaboration
Exploration of how physicians can refer patients to pharmacy-led RPM programs, fostering proactive, preventive care.
- 1:10:08Patient Education and Engagement Strategies
Emphasis on explaining the 'why' behind monitoring tasks to improve patient adherence and outcomes.
Highlights
- 0:53
Compounded Peptides Policy Under Reviewinsight
The FDA submitted an interim access policy for certain compounded peptides to the White House for regulatory review, with potential temporary enforcement discretion under consideration.
- 15:39
Rural Healthcare Transformation Program Fundingdata
The Federal Rural Health Transformation Program represents a $50 billion investment from 2026 to 2030 to help fill healthcare gaps and support independent pharmacies.
- 24:22
State Grant Use Cases for Pharmaciesstrategy
State pharmacy associations have requested funds for remote dispensing devices and AI workflow solutions to help pharmacies manage staffing shortages.
- 55:43
Hypertension Diagnosis and Monitor Purchasedata
Focus groups and research show that if a patient diagnosed with hypertension does not buy a blood pressure monitor within seven days, they generally do not purchase one at all.
- 1:05:20
Reduction in Hospital Readmissionsdata
Studies show that remote patient monitoring models can lead to a 20% decrease in hospital readmissions, saving healthcare dollars across the spectrum.
- 1:08:56
Daily Weight Monitoring for Heart Failureinsight
Tracking daily weight with a scale is critical for heart failure patients to prevent readmissions, though patients often make excuses for weight fluctuations.
- 1:14:02
Cellular GatewaySimplifies Data Collectionstrategy
Tenovi utilizes a simple cellular gateway in the patient's home instead of Wi-Fi or apps to ensure high utilization and adoption rates for remote monitoring.
Quotes
“The protection comes down to the pharmacist being in charge of compounding in the first place.”
Unnamed speaker · 1:46 “Patients receiving the drug experienced significantly more pain free time in sunlight compared with placebo.”
Unnamed speaker · 5:28 “The public is terribly unmannered and in some of the most disgusting people out there sometimes, the way that they treat technicians and pharmacists.”
Unnamed speaker · 7:41 “You know, it was like, it was, it was hard for them to get to talk to the physician if they're only there twice a week, you know, it was hard for them to connect.”
Unnamed speaker · 1:02:35 “And I think that's again, another huge opportunity for community pharmacy to, to play that role.”
Unnamed speaker · 1:03:48 “When you look at some studies show it was a 20% decrease in readmissions, that's massive.”
Unnamed speaker · 1:05:20 “And I think that's where the pharmacy can come in so beautifully, if you will.”
Unnamed speaker · 1:11:13
Sponsored segments
- IPCRx 1:16:25–1:16:41
- Tenovi 1:16:32–1:17:35
About this episode
October 23, 2026Sponsored by Independent Pharmacy Cooperative and YARAL Pharma This week on TWIRx: peptide compounding policy, a new hepatitis B treatment, specialty pharmacy growth, a rare-disease breakthrough, and pharmacy workforce pressure — followed by three conversations focused on the future of independent pharmacy. TWIRx NEWS 1. FDA Moves Peptide Policy to White House Review The FDA has submitted an Interim Access Policy for Compounding Using Certain Peptides for White House review. No final policy has been announced. Why it matters: A temporary pathway could move some patients away from gray-market peptide sellers and toward licensed pharmacies, while raising ongoing questions about safety and evidence. TWIRx angle: Is regulated compounding safer than leaving patients to buy peptides online? 2. FDA Approves GSK’s Hibsago for Chronic Hepatitis B FDA approved Hibsago, bepirovirsen, for certain adults with chronic hepatitis B. In Phase III studies, about 19% of eligible treated patients achieved functional cure after therapy stopped. Why it matters: This could move hepatitis B treatment beyond long-term viral suppression toward sustained disease control for some patients. 3. Carelon Specialty Pharmacy Helps Drive Growth Elevance Health reported $19.3 billion in quarterly Carelon revenue and about $900 million in operating gain, citing CarelonRx growth and improved specialty-pharmacy profitability. Why it matters: Specialty pharmacy continues to become a major earnings and strategic growth engine inside vertically integrated healthcare organizations. 4. Positive Phase III Results for Bitopertin Disc Medicine reported positive Phase III results for bitopertin in rare disorders where exposure to light can cause severe pain. Patients experienced improved light tolerance and fewer phototoxic reactions. Why it matters: This could meaningfully improve daily life for patients whose disease forces them to avoid sunlight. 5. Pharmacy Technicians Describe Growing Pressure A widely discussed Reddit thread featured pharmacy technicians describing prescription backlogs, nonstop phones, frustrated patients, and inadequate staffing. Important disclaimer: These are anonymous accounts and cannot be independently verified. TWIRx angle: Are pharmacy teams being asked to do more without enough staffing and infrastructure? FEATURED CONVERSATIONS Mark Kinney — IPC IPC is expanding its Government Relations team as independent pharmacies face major federal and state issues involving PBM reform, reimbursement, rural access, and patient choice. Discussion focus: Why IPC is investing more heavily in advocacy and what pharmacy owners should expect heading into 2027. Shelley Bailey — IPC Rural Health and Independent Pharmacy Independent pharmacies often serve as critical healthcare access points in rural communities. Discussion focus: Pharmacy closures and rural access Chronic disease management Pharmacist clinical services Reimbursement and provider opportunities Why rural pharmacies should be treated as healthcare infrastructure Kelli Stovall, IPC + Brandon Haag, Tenovi Remote Monitoring Beyond the Pharmacy Counter IPC and Tenovi are partnering to give independent pharmacies access to RPM and RTM technology, including blood pressure monitors, scales, smart pillboxes, and inhaler sensors. The goal is to support: Medication adherence Hypertension and chronic disease management Weight management Respiratory care Cash-pay and reimbursable clinical services Big question: Can remote monitoring help independent pharmacies improve patient care while creating sustainable new revenue? Closing Independent pharmacy’s future increasingly depends on three things: A stronger voice. A broader clinical role. Sustainable new economic models that keep care local. TWIRx is sponsored by Independent Pharmacy Cooperative and YARAL Pharma. Independent Pharmacy: Power, Policy & Patient Care | TWIRx
Transcript
12,094 words · 8 speakers
Topics
- IPC
- Starlink
- CMS
- remote patient monitoring
- FDA
- rural areas
- RHTP
- EHR
- United States
- hospitals
Page updated · transcript and summary are machine-generated